U.S. Nutraceutical Market Predicted to Generate 8% CAGR Through 2015: PharmaLive Special Report

NEWTOWN, Pa., November 4, 2011 - The world nutraceutical market
is expected to reach more than $180 billion in 2017 due to the
aging population, increased prevalence of serious diseases, and an
enhanced focus on preventative medicine. The U.S. nutraceutical
market is among the largest and fastest-growing sectors in the
world, predicted to generate a compound annual growth rate of more
than 7% from this year through 2015.

Multivitamins remain the most popular nutraceutical supplement,
followed by calcium, omega-3, vitamin C, and vitamin D. The
popularity of these supplements relates to the perception that the
typical daily diet does not contain enough essential
nutrients.
Driven by consumers' desire to improve their health, the
nutraceutical market must focus on scientific evidence backing the
efficacy claims of products to maintain growth. Consumer education
and the emergence of quality control of nutraceutical products will
also help drive industry growth.

"The global nutraceutical industry is on track to generate
annual sales growth of about 5% during the next few years, paced by
the U.S. market,” says Andrew Humphreys, editor in chief of
UBM Canon Data Products. "Emerging markets are also helping drive
worldwide growth, such as India. That country's nutraceutical sales
are projected to more than double between now and 2015."

One of the first companies to enter and create this market was
Metagenics Inc. Founded in 1983, Metagenics is a nutrigenomics and
lifestyle medicine company dedicated to reducing chronic illness
and improving health. Through its substantial and continuing
commitment to nutrigenomic research, the company has been able to
identify natural compounds with powerful therapeutic applications
to be used in Metagenics' science-based TLC programs, medical
foods, and nutraceuticals.

Metagenics recently presented research at the National Lipid
Association 2011 Annual Scientific Sessions in New York. The
research demonstrated the effectiveness of omega-3 supplements for
heart health and the long-term impact of a lifestyle medicine
program. Significant improvements were observed in body weight,
body mass index, percent lean body mass, percent fat mass, and
total cholesterol of those that entered a lifestyle medicine
program for one year.

The company has 43 patents and more than 230 pending patents.
Metagenics' U.S. medical food products include Bariatrix
Essentials, Estrium, UltraCare for Kids, UltraClear, UltraGlycemX,
UltraInflamX, and UltraMean.

More information is available in Nutraceuticals and Vitamins
Review and Outlook 2011, located at
www.pharmalive.com/specialreports.

For additional information, contact Sandra Baker at
+1-215-944-9836 or Sandra.Baker@ubm.com.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.